Major trial tests promising drug to reverse scarring in fatty liver disease
Disease control
Ongoing
This large, late-stage study is testing whether a drug called efruxifermin is safe and effective for people with a serious form of fatty liver disease called NASH or MASH. About 700 adults with the disease will receive either the drug or a placebo for a period of time. The main g…
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC